Published in Anal Biochem on July 01, 1991
Theoretical uncertainty of measurements using quantitative polymerase chain reaction. Biophys J (1996) 3.30
Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol (1995) 2.90
Identification of enteroviruses in clinical specimens by competitive PCR followed by genetic typing using sequence analysis. J Clin Microbiol (1996) 1.64
Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res (1993) 1.62
Diversity of the abundant pKLC102/PAGI-2 family of genomic islands in Pseudomonas aeruginosa. J Bacteriol (2006) 1.43
Differential priming of RNA templates during cDNA synthesis markedly affects both accuracy and reproducibility of quantitative competitive reverse-transcriptase PCR. Biochem J (1999) 1.39
CFTR and differentiation markers expression in non-CF and delta F 508 homozygous CF nasal epithelium. J Clin Invest (1995) 1.10
Spontaneous rescue from cystic fibrosis in a mouse model. BMC Genet (2006) 0.87
cDNA and genomic cloning and expression of the P48 monocytic differentiation/activation factor, a Mycoplasma fermentans gene product. Biochem J (1996) 0.85
Determination of oestrogen responsiveness of breast cancer by competitive reverse transcription-polymerase chain reaction. Br J Cancer (1995) 0.77
Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440. Environ Microbiol (2002) 8.11
Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell (1995) 5.61
Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci U S A (1990) 4.74
Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell (1992) 4.71
Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med (1990) 4.60
Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol (1988) 4.27
Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics (1991) 4.27
Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science (1983) 3.88
Phosphorylation-regulated Cl- channel in CHO cells stably expressing the cystic fibrosis gene. Nature (1991) 3.61
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature (1985) 3.59
Assignment of the gene for myelin proteolipid protein to the X chromosome: implications for X-linked myelin disorders. Science (1985) 3.43
Multi-ion pore behaviour in the CFTR chloride channel. Nature (1993) 3.14
A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl Environ Microbiol (1994) 3.02
Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J (1994) 2.93
Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites. J Biol Chem (1993) 2.85
The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J Biol Chem (1993) 2.65
Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland. Nat Genet (1992) 2.64
Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis (1994) 2.64
A physical genome map of Pseudomonas aeruginosa PAO. EMBO J (1989) 2.60
Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome. EMBO J (1998) 2.55
Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis. J Clin Microbiol (2000) 2.41
Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. J Clin Microbiol (1999) 2.36
Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (1994) 2.27
Permeability of wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride channels to polyatomic anions. J Gen Physiol (1997) 2.26
Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin Infect Dis (1999) 2.18
DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression. Mol Cell Biol (1982) 2.03
Sequence diversity of Pseudomonas aeruginosa: impact on population structure and genome evolution. J Bacteriol (2000) 1.98
Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J Biol Chem (1979) 1.98
New approaches in genome analysis by pulsed-field gel electrophoresis: application to the analysis of Pseudomonas species. Mol Microbiol (1991) 1.98
DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis. J Clin Invest (1999) 1.97
Comparative genome mapping of Pseudomonas aeruginosa PAO with P. aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats. J Bacteriol (1996) 1.93
Large genome rearrangements discovered by the detailed analysis of 21 Pseudomonas aeruginosa clone C isolates found in environment and disease habitats. J Mol Biol (1997) 1.93
Genetic and biochemical characterization of multidrug resistance. Pharmacol Ther (1985) 1.92
Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis. Thorax (2009) 1.90
Cl- channel activity in Xenopus oocytes expressing the cystic fibrosis gene. J Biol Chem (1991) 1.86
Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts. Antimicrob Agents Chemother (1986) 1.83
MSP RFLP for X-linked proteolipid protein gene (PLP) identified with either rat or human PLP cDNA clone. Nucleic Acids Res (1987) 1.80
Voltage-dependent block of the cystic fibrosis transmembrane conductance regulator Cl- channel by two closely related arylaminobenzoates. J Gen Physiol (1993) 1.74
Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations. Arch Microbiol (2001) 1.73
A physical genome map of the Burkholderia cepacia type strain. Mol Microbiol (1995) 1.73
Multidrug-resistance phenotype in Chinese hamster ovary cells. Cancer Treat Rep (1983) 1.72
The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun (1986) 1.71
Genomic mapping of Pseudomonas aeruginosa PAO. Microbiology (1994) 1.69
Physical and genetic map of the Neisseria gonorrhoeae strain MS11-N198 chromosome. Mol Microbiol (1991) 1.67
DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase. Thorax (1995) 1.67
Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity. J Biol Chem (1996) 1.66
Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings. J Clin Invest (2001) 1.63
Dual effects of ADP and adenylylimidodiphosphate on CFTR channel kinetics show binding to two different nucleotide binding sites. J Gen Physiol (1999) 1.61
Genetic diversity of flagellins of Pseudomonas aeruginosa. FEBS Lett (1996) 1.57
Physical genome analysis of bacteria. Electrophoresis (1993) 1.56
Synthesis of multiple N-acylhomoserine lactones is wide-spread among the members of the Burkholderia cepacia complex. Syst Appl Microbiol (2001) 1.54
Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res (1983) 1.53
Regulation of CFTR ion channel gating by MgATP. FEBS Lett (1998) 1.46
Removal of multiple arginine-framed trafficking signals overcomes misprocessing of delta F508 CFTR present in most patients with cystic fibrosis. Mol Cell (1999) 1.45
Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis. Lancet (1993) 1.42
The impact of two-dimensional pulsed-field gel electrophoresis techniques for the consistent and complete mapping of bacterial genomes: refined physical map of Pseudomonas aeruginosa PAO. Nucleic Acids Res (1991) 1.42
Mapping of cystic fibrosis transmembrane conductance regulator membrane topology by glycosylation site insertion. J Biol Chem (1994) 1.42
Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (2001) 1.39
Clinical presentation of exclusive cystic fibrosis lung disease. Thorax (1999) 1.39
The cystic fibrosis transmembrane regulator is present and functional in endosomes. Role as a determinant of endosomal pH. J Biol Chem (1992) 1.38
The non-hydrolytic pathway of cystic fibrosis transmembrane conductance regulator ion channel gating. J Physiol (2000) 1.38
CFTR is a monomer: biochemical and functional evidence. J Membr Biol (2002) 1.38
Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe. Hum Genet (2000) 1.37
Genome organization of Pseudomonas stutzeri and resulting taxonomic and evolutionary considerations. Int J Syst Bacteriol (1997) 1.37
Human fetal liver contains both zinc- and copper-rich forms of metallothionein. J Biol Chem (1980) 1.35
Phosphatase inhibitors activate normal and defective CFTR chloride channels. Proc Natl Acad Sci U S A (1994) 1.34
Dibasic protein kinase A sites regulate bursting rate and nucleotide sensitivity of the cystic fibrosis transmembrane conductance regulator chloride channel. J Physiol (1998) 1.33
Direct action of genistein on CFTR. Pflugers Arch (1997) 1.32
Phosphorylation by cAMP-dependent protein kinase causes a conformational change in the R domain of the cystic fibrosis transmembrane conductance regulator. Biochemistry (1994) 1.32
Rhamnolipid of Pseudomonas aeruginosa in sputum of cystic fibrosis patients. Lancet (1987) 1.29
Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics. Twin Res (2000) 1.29
Monitoring genome evolution ex vivo: reversible chromosomal integration of a 106 kb plasmid at two tRNA(Lys) gene loci in sequential Pseudomonas aeruginosa airway isolates. Microbiology (2000) 1.29
ATPase activity of purified multidrug resistance-associated protein. J Biol Chem (1997) 1.29
Production of N-acyl-L-homoserine lactones by P. aeruginosa isolates from chronic lung infections associated with cystic fibrosis. FEMS Microbiol Lett (2000) 1.28
Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report. J Cyst Fibros (2011) 1.28
Allosteric interactions between the two non-equivalent nucleotide binding domains of multidrug resistance protein MRP1. J Biol Chem (2000) 1.27
Disease-associated mutations in cytoplasmic loops 1 and 2 of cystic fibrosis transmembrane conductance regulator impede processing or opening of the channel. Biochemistry (1997) 1.25
Inhibition of epithelial Na+ currents by intracellular domains of the cystic fibrosis transmembrane conductance regulator. FEBS Lett (1997) 1.24
Gradient of genomic diversity in the Pseudomonas aeruginosa chromosome. Mol Microbiol (1995) 1.24
cAMP-inducible chloride conductance in mouse fibroblast lines stably expressing the human cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci U S A (1991) 1.23
Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros (2011) 1.23
cAMP-dependent protein kinase-mediated phosphorylation of cystic fibrosis transmembrane conductance regulator residue Ser-753 and its role in channel activation. J Biol Chem (1995) 1.22
Cytoplasmic loop three of cystic fibrosis transmembrane conductance regulator contributes to regulation of chloride channel activity. J Biol Chem (1996) 1.21
Structural and functional implications of sequence diversity of Pseudomonas aeruginosa genes oriC, ampC and fliC. Electrophoresis (1998) 1.21
Virulence factors of Pseudomonas aeruginosa. Antibiot Chemother (1971) (1987) 1.21
Long-term tobramycin aerosol therapy in cystic fibrosis. Pediatr Pulmonol (1989) 1.20
Phosphorylation of protein kinase C sites in NBD1 and the R domain control CFTR channel activation by PKA. J Physiol (2003) 1.19
Regulation of CFTR expression and function during differentiation of intestinal epithelial cells. EMBO J (1992) 1.18
Phenotypic abnormalities in long-term surviving cystic fibrosis mice. Pediatr Res (1996) 1.16
Receptors that couple to 2 classes of G proteins increase cAMP and activate CFTR expressed in Xenopus oocytes. Receptors Channels (1993) 1.15
Bicarbonate permeability of the outwardly rectifying anion channel. J Membr Biol (1989) 1.14
Intracellular localization of GDP-L-fucose:glycoprotein and CMP-sialic acid: apolipoprotein glycosyltransferases in rat and pork livers. Arch Biochem Biophys (1975) 1.14
Study of the expression of myelin proteolipid protein (lipophilin) using a cloned complementary DNA. Nucleic Acids Res (1985) 1.13
Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells. J Biol Chem (1993) 1.13
Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers. Vaccine (2001) 1.12
Residual chloride secretion in intestinal tissue of deltaF508 homozygous twins and siblings with cystic fibrosis. The European CF Twin and Sibling Study Consortium. Gastroenterology (2000) 1.10
CFTR and differentiation markers expression in non-CF and delta F 508 homozygous CF nasal epithelium. J Clin Invest (1995) 1.10
Interactions of lectins with membrane glycoproteins. Effects of concanavalin A on 5'-nucleotidase. Biochim Biophys Acta (1974) 1.09
The cystic fibrosis transmembrane conductance regulator chloride channel. Iodide block and permeation. Biophys J (1992) 1.08
Expression and degradation of the cystic fibrosis transmembrane conductance regulator in Saccharomyces cerevisiae. Arch Biochem Biophys (2001) 1.08